Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
CIK: 1967150
All Transactions
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Feb 12, 2026 | Enliven Therapeutics, Inc. (ELVN) | A | 18,750 | $0.00 | $0.00 | View Details Filing |
| Feb 12, 2026 | Enliven Therapeutics, Inc. (ELVN) | A | 112,500 | $0.00 | $0.00 | View Details Filing |
| Feb 6, 2026 | Enliven Therapeutics, Inc. (ELVN) | S | 5,000 | $29.04 | $145,219.00 | View Details Filing |
| Jan 20, 2026 | Enliven Therapeutics, Inc. (ELVN) | S | 5,491 | $26.37 | $144,814.14 | View Details Filing |
| Jan 20, 2026 | Enliven Therapeutics, Inc. (ELVN) | S | 14,509 | $26.90 | $390,284.85 | View Details Filing |
| Jan 9, 2026 | Enliven Therapeutics, Inc. (ELVN) | S | 50,000 | $29.13 | $1,456,715.00 | View Details Filing |
| Jan 9, 2026 | Enliven Therapeutics, Inc. (ELVN) | S | 41,198 | $24.90 | $1,025,863.16 | View Details Filing |
| Jan 8, 2026 | Enliven Therapeutics, Inc. (ELVN) | S | 7,500 | $20.13 | $150,961.50 | View Details Filing |
| Jan 8, 2026 | Enliven Therapeutics, Inc. (ELVN) | S | 33,802 | $24.92 | $842,474.29 | View Details Filing |